164 related articles for article (PubMed ID: 8523355)
1. Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants.
Yeh LA; Augustine AJ; Lee P; Riviere LR; Sheldon A
J Rheumatol; 1995 Sep; 22(9):1740-6. PubMed ID: 8523355
[TBL] [Abstract][Full Text] [Related]
2. Comparative and combined effects of interleukin 6, interleukin 1 beta, and tumor necrosis factor alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose.
Malfait AM; Verbruggen G; Veys EM; Lambert J; De Ridder L; Cornelissen M
J Rheumatol; 1994 Feb; 21(2):314-20. PubMed ID: 8182643
[TBL] [Abstract][Full Text] [Related]
3. Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage.
Sui Y; Lee JH; DiMicco MA; Vanderploeg EJ; Blake SM; Hung HH; Plaas AH; James IE; Song XY; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2009 Oct; 60(10):2985-96. PubMed ID: 19790045
[TBL] [Abstract][Full Text] [Related]
4. Effects of stromelysin activity on proteoglycan degradation of canine articular cartilage explants.
Todhunter RJ; Yeh LA; Sheldon A; Grisanzio L; Walker SL; Burton-Wurster N; Lust G
Am J Vet Res; 1995 Sep; 56(9):1241-7. PubMed ID: 7486406
[TBL] [Abstract][Full Text] [Related]
5. Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines.
Patwari P; Cook MN; DiMicco MA; Blake SM; James IE; Kumar S; Cole AA; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2003 May; 48(5):1292-301. PubMed ID: 12746902
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of interleukin 1-mediated proteoglycan degradation in bovine articular cartilage explants by addition of sodium hyaluronate.
Morris EA; Wilcon S; Treadwell BV
Am J Vet Res; 1992 Nov; 53(11):1977-82. PubMed ID: 1466488
[TBL] [Abstract][Full Text] [Related]
7. Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate.
Chan PS; Caron JP; Orth MW
J Rheumatol; 2006 Jul; 33(7):1329-40. PubMed ID: 16821268
[TBL] [Abstract][Full Text] [Related]
8. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
[TBL] [Abstract][Full Text] [Related]
9. Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments.
Homandberg GA; Hui F
Arch Biochem Biophys; 1996 Oct; 334(2):325-31. PubMed ID: 8900407
[TBL] [Abstract][Full Text] [Related]
10. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor.
Alsalameh S; Mattka B; Al-Ward R; Lorenz HM; Manger B; Pfizenmaier K; Grell M; Kalden JR
J Rheumatol; 1999 Mar; 26(3):645-53. PubMed ID: 10090177
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 17 induced nitric oxide suppresses matrix synthesis and protects cartilage from matrix breakdown.
Cai L; Suboc P; Hogue DA; Fei DT; Filvaroff EH
J Rheumatol; 2002 Aug; 29(8):1725-36. PubMed ID: 12180737
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
13. Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage.
Hardingham TE; Bayliss MT; Rayan V; Noble DP
Br J Rheumatol; 1992; 31 Suppl 1():1-6. PubMed ID: 1532522
[TBL] [Abstract][Full Text] [Related]
14. Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.
Maneiro E; López-Armada MJ; Fernández-Sueiro JL; Lema B; Galdo F; Blanco FJ
J Rheumatol; 2001 Dec; 28(12):2692-9. PubMed ID: 11764219
[TBL] [Abstract][Full Text] [Related]
15. Production of cytokines by chondrocytes and its role in proteoglycan degradation.
Shinmei M; Masuda K; Kikuchi T; Shimomura Y; Okada Y
J Rheumatol Suppl; 1991 Feb; 27():89-91. PubMed ID: 2027138
[TBL] [Abstract][Full Text] [Related]
16. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-1 activity is inhibited by interleukin-1 alpha, tumor necrosis factor-alpha, and interleukin-6.
Lazarus DD; Moldawer LL; Lowry SF
Lymphokine Cytokine Res; 1993 Aug; 12(4):219-23. PubMed ID: 8218594
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit.
Arner EC; Harris RR; DiMeo TM; Collins RC; Galbraith W
J Rheumatol; 1995 Jul; 22(7):1338-46. PubMed ID: 7562769
[TBL] [Abstract][Full Text] [Related]
19. Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats.
Yamamoto N; Sakai F; Yamazaki H; Kawai Y; Nakahara K; Okuhara M
J Rheumatol; 1996 Oct; 23(10):1778-83. PubMed ID: 8895158
[TBL] [Abstract][Full Text] [Related]
20. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4.
Lubberts E; Joosten LA; van de Loo FA; van den Gersselaar LA; van den Berg WB
Arthritis Rheum; 2000 Jun; 43(6):1300-6. PubMed ID: 10857788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
